CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- 424B5 Offering Prospectus
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award President & CEO acquired 375,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 112,500 shares (grant or award)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,715 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 11,839 shares (to pay taxes)
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
Page 3 of 47 · 923 filings